Raymond James Financial Inc Eton Pharmaceuticals, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 11,043 shares of ETON stock, worth $196,234. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,043Holding current value
$196,234% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ETON
# of Institutions
54Shares Held
9.1MCall Options Held
261KPut Options Held
500-
Opaleye Management Inc. Boston, MA2.78MShares$49.4 Million3.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$18.3 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT999KShares$17.7 Million0.36% of portfolio
-
Westside Investment Management, Inc.575KShares$10.2 Million1.61% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA566KShares$10.1 Million0.15% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $450M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...